1. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population
   Marta Podralska et al, 2018, BMC Cancer CrossRef
2. High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
   Birgitte Bertelsen et al, 2019, npj Genom. Med. CrossRef
3. null
   Apichat Tantraworasin et al, 2019 CrossRef
4. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
   Lei Bian et al, 2019, Mol Cancer CrossRef
5. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach
   Samuele Lodovichi et al, 2020, IJMS CrossRef
6. Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
   Negesse Mekonnen et al, 2022, Front. Oncol. CrossRef
7. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects
   Sami Belhadj et al, 2023 CrossRef